Fred Hutchinson Cancer Center provides symposiums, webinars and other educational programs about specific disease programs focusing on advancements to diagnostic techniques and treatment modalities. Our programs feature physician speakers from Fred Hutch, UW Medicine and Seattle Children’s.
We strive to support Fred Hutch’s mission of advancing the standard of oncology care throughout the region by providing high quality medical education to healthcare providers. Our oncology-specific education services focus on current and emerging standards of care and treatment options along the cancer care continuum with the goal of improving patient outcomes.
Practical clinical training
In addition to symposiums and webinars, Fred Hutch offers other clinical education including multi-day training courses and shadowing programs.
Fred Hutch offers educational symposiums throughout the year, with focuses on research advancements to diagnostic techniques and treatment modalities.
On-demand course available December 1, 2022 – November 30, 2023
This educational program will cover data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.
May 5, 2023
Presented by Fred Hutch and Swedish, this single-day course will provide leading-edge information for clinicians who care for patients with benign and malignant thyroid disorders. A multidisciplinary panel of experts will discuss the most recent clinical innovations and new management protocols for treating thyroid nodules, thyroiditis, and thyroid cancer.
May 19, 2023
Join nationally-renowned experts from Fred Hutchinson Cancer Center for this one-day symposium in Seattle, WA. Researchers and health care professionals caring for patients with breast cancer will learn to assess clinical practice and research findings to advance care of breast malignancies, reduce mortality rates, and increase survival rates.
Immune-Related Adverse Events – A Series of Panels Exploring the Side Effects of Immunotherapy
Immune-Related Adverse Events (irAEs), provider-focused discussions on immunotherapy-related treatment, research updates and clinical challenges.
The 90-minute sessions are approximately half didactic information presented by experts in the field and half panel case discussion and questions. Series co-chaired by Shailender Bhatia, MD and Petros Grivas, MD, PhD.
Accreditation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Washington School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit.)